AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 1 filers reported holding AMRYT PHARMA PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,510,964 | – | 103,775 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 4,520,000 | $54,443,000 | 34.53% |
| Stonepine Capital Management, LLC | 5,801,748 | $69,882,000 | 31.80% |
| MPM ASSET MANAGEMENT LLC | 2,668,845 | $32,160,000 | 7.45% |
| Healthcare Value Capital, LLC | 250,000 | $3,023,000 | 5.97% |
| Global Frontier Investments LLC | 410,000 | $4,938,000 | 3.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 516,221 | $6,218,000 | 3.52% |
| Aquilo Capital Management, LLC | 1,390,000 | $16,743,000 | 3.04% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $5,417,000 | 1.56% |
| Rubric Capital Management LP | 3,257,005 | $39,231,000 | 1.10% |
| Bruce & Co., Inc. | 407,440 | $4,925,000 | 1.05% |